UK's First Rollout of AI-based Cancer Detection for NHS Patients as Pathology Provider LDPath Teams Up with Ibex Medical Analytics
In recent years, a global increase in cancer cases has coincided with a decline in the number of pathologists around the world.
- In recent years, a global increase in cancer cases has coincided with a decline in the number of pathologists around the world.
- Limited availability of pathologists requires couriers to transport glass slides containing tissue samples between different locations to access expert opinions.
- LDPath pathologists will be alerted in the event of significant discrepancy between their diagnosis and the algorithm's findings (e.g.
- "We are proud to be the first UK pathology provider to integrate AI into the digital pathology workflow by partnering with Ibex to improve cancer diagnosis," said Sanj Lallie, Director of Operations at LDPath.